These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30993901)

  • 1. Effect of histological subtype and treatment modalities on T1-2 N0-1 small cell lung cancer: A population-based study.
    Moon SW; Seo JH; Jeon HW; Moon MH
    Thorac Cancer; 2019 May; 10(5):1229-1240. PubMed ID: 30993901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry.
    Lara JD; Brunson A; Riess JW; Kelly K; Lara PN; Gandara DR
    Lung Cancer; 2017 Oct; 112():165-168. PubMed ID: 29191590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
    Xu L; Zhang G; Song S; Zheng Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
    Abdel-Rahman O
    Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer (SCLC) after surgical resection.
    Guo Y; Yang L; Liu L; Wei J; Teng F; Zhang J; Zhu Y; Xing P; Li J
    Thorac Cancer; 2020 Oct; 11(10):2782-2792. PubMed ID: 32779385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resected Pure Small Cell Lung Carcinomas and Combined Small Cell Lung Carcinomas: Histopathology Features, Imaging Features, and Prognoses.
    Woo JH; Kim MY; Lee KS; Jeong DY; Chung MJ; Han J; Shim YM
    AJR Am J Roentgenol; 2019 Apr; 212(4):773-781. PubMed ID: 30673331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cause-specific death assessment of patients with stage I small-cell lung cancer: a competing risk analysis.
    Liu J; Zhou H; Zhang Y; Fang W; Yang Y; Hong S; Chen G; Zhao S; Chen X; Zhang Z; Xian W; Shen J; Huang Y; Zhao H; Zhang L
    Future Oncol; 2019 Jul; 15(21):2479-2488. PubMed ID: 31238738
    [No Abstract]   [Full Text] [Related]  

  • 8. Propensity Score Matching Analysis for the Role of Surgery in Small Cell Lung Cancer.
    Wei S; Wei B; Tian J; Song X; Wu B; Hu P
    Oncol Res Treat; 2020; 43(6):276-288. PubMed ID: 32392569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III.
    Wang H; Zhang J; Shi F; Zhang C; Jiao Q; Zhu H
    Oncotarget; 2017 May; 8(21):34923-34934. PubMed ID: 28432275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
    Ignatius Ou SH; Zell JA
    J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
    Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
    BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram to predict cause-specific mortality in extensive-stage small cell lung cancer: A competing risk analysis.
    Zhong J; Zheng Q; An T; Zhao J; Wu M; Wang Y; Zhuo M; Li J; Zhao X; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
    Thorac Cancer; 2019 Sep; 10(9):1788-1797. PubMed ID: 31318178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study on the impact of radiotherapy on the survival outcomes of small cell lung cancer patients based on the SEER database.
    Chen Y; Yao L; Chen Q; Hu Y; Zhu X; Dai R; Chen X; Zeng Y; Zhu Y; Song D; Zhang Y
    Sci Rep; 2024 Jul; 14(1):15552. PubMed ID: 38969694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
    Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
    Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP1 protein expression has variant prognostic significance in small cell lung cancer (SCLC) stratified by histological subtypes.
    Wang X; Guo Y; Liu L; Wei J; Zhang J; Xie T; Dong J; Li J; Xing P; Yang L
    Lung Cancer; 2021 Oct; 160():166-174. PubMed ID: 34364705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of examined lymph node count on survival outcomes in patients with stage T1-2N0M0 small cell lung cancer undergoing surgery: A retrospective cohort study.
    Wan XB; Liang HW; Liu Y; Huang W; Pan XB
    Medicine (Baltimore); 2024 May; 103(22):e38381. PubMed ID: 39259081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The number of lymph nodes examined is associated with survival outcomes and nodal upstaging in patients with stage I small cell lung cancer.
    Chen Y; Zhang J; Jiang C; Zhang H; Fan P; Yu H; Zhang H; Fei K; Zhang P
    Surg Oncol; 2021 Jun; 37():101513. PubMed ID: 33429326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of candidates for surgery as local therapy among early-stage small cell lung cancer patients: a population-based analysis.
    Jin K; Zhang K; Zhou F; Dai J; Zhang P; Jiang G
    Cancer Commun (Lond); 2018 Mar; 38(1):5. PubMed ID: 29764484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer.
    Shojaee S; Singh I; Solsky I; Nana-Sinkam P
    Respiration; 2019; 98(3):198-202. PubMed ID: 31121583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
    Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
    Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.